Internally, these boundaries are changing in terms of the increased responsibility of corporations towards their direct and indirect internal stakeholders. This is shown through innovations in business practice to achieve enhanced social justice in the workplace, improved governance, and more accurate disclosure of non-financial risk. This paper provides a context for this discussion by examining emerging international law, guidelines and voluntary initiatives, regulatory frameworks, and risk review procedures that increasingly seek to redefine corporate responsibility by establishing new norms of best practice and behaviour. These boundaries are also expanding externally, as society increasingly expects global business to work with others to provide solutions to humanitarian crises and endemic problems facing the world. This paper explores how some companies are doing this by applying core competencies in ways that integrate social development and business goals. It suggests, in turn, that the challenges of these expanding boundaries of responsibilities are best addressed through strategic partnerships.

Question 1

What is the meaning of the international normalized ratio (INR) blood test?

Question 2

What is the cause of moderate thrombocytopenia in Bernard-Soulier

syndrome? It is a qualitative defect not a quantitative platelet disorder.

Question 3

What is new about thrombopoietin?

Question 4

What is the rationale behind the use of desmopressin in bleeding

disorders?

Question 5

What effect does the contraceptive pill have on the blood fibrinogen level

and on blood coagulability?

Question 6

Does standard (unfractionated) heparin in doses of 10 000-15 000

units/day need monitoring?

Question 7

Is there an antidote for low-molecular-weight heparin (LMWH)? Can

Enoxaprin be used?

Question 8

1. What is the mechanism of the action of aprotinin?

2. What is the therapeutic window for aprotinin?

3. In a case of haemorrhagic stroke, how many days should aprotinin be

prescribed for and what is the recommended dosage?

Question 9

My question is, what are thrombophilia scan tests? Can we use these in

patients on anticoagulant therapy?

Question 10

In thromboembolic disorders, how is clopidogrel superior to aspirin?4150